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Abstract
Objective: Several studies have suggested that type of laryngeal biopsy may impact voice and vocal function, which may ultimately influence functional outcomes post 
cancer treatment. This study directly examined the impact of the biopsy procedure on voice outcomes for early glottic (Tis-T2) cancer patients. 
Design: Prospective pilot cohort study. 
Method: Fifteen patients diagnosed with early glottic cancer underwent voice recordings within one week pre-biopsy and between one-six weeks post-biopsy, 
via Sahlgrenska University Hospital, Sweden. A control group (n=15), matched for gender and comparable for age and smoking status, was assessed once only. 
Multidimensional voice analyses were conducted with both groups including: (1) Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS) perceptual rating, (2) 
acoustic measures of harmonics to noise ratio, jitter, shimmer, mean spoken fundamental frequency and (3) Maximum Phonation Time (MPT). 
Results: In comparison to the control group, most perceptual and acoustic parameters were significantly (P<0.05) more impaired both pre and post biopsy. No 
significant difference (P>0.05) in the patient cohort was observed between pre-post biopsy voice parameters. At an individual level, half of the patients showed a 
perceived change in voice post biopsy, of which four demonstrated improvement and three a deterioration in vocal function. 
Implications: Although group level analysis did not show a significant biopsy-voice impact, individual data suggests that multiple, punch biopsies may negatively 
impact functional outcomes. The biopsy procedure is undoubtedly a necessary first step in laryngeal cancer management; however, given the emerging discussion 
regarding the type of biopsy technique, the nature and the extent of tumour/tissue removal on functional outcomes, this is an area for further research. 
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Introduction
Larynx cancer is the second most common malignancy of the 
respiratory tract and of all head and neck cancers [1,2], with glottic 
carcinoma the most common type [3]. To date the majority of research 
on voice outcomes following early glottic cancer (Tis-T2) has explored 
the impact of either radiotherapy or transoral laser microsurgery on 
voice quality and functional outcomes [4-6]. Findings from this body 
of research suggests that both methods of organ-preservation treatment 
impact vocal quality and function to a similar extent, with the majority 
of patients expected to present with persistent, predominantly mild-
moderate changes to voice quality [7-9]. Whilst numerous mechanisms 
relating to either the radiotherapy or surgical procedures have been 
proposed to be the cause of such vocal change, few studies have explored 
the potential impact of the earliest procedure on patient outcomes, that 
of the biopsy [10-13]. 
The biopsy, an important key step in the initial diagnostic process 
for laryngeal cancer, can occur using a variety of techniques and is 
dependent upon lesion characteristics (superficial versus invasive 
versus exophytic), location of the lesion and individual surgeon 
skill and preferences [1,14,15]. For glottic tumours, the endoscopic 
excisional biopsy is favourably reported since it has the dual purpose 
in that it is both diagnostic and optimises therapeutic outcomes in a 
single procedure [14,16,17]. An excisional biopsy removes the entire 
pathological tissue whilst endeavouring to preserve structures of the 
vocal cords and is argued to be superior to the punch biopsy which may 
harm the vocal cords [14]. Vocal cord stripping (removal of the top 
most layers of tissue along the vocal cords) may also occur as a biopsy 
procedure [12,13,18]. 
Numerous authors lay claim that the biopsy process may influence 
voice and functional outcomes [11-13,18], however the possible 
biopsy-voice impact has not been systematically investigated in a 
single study to date. All studies, discussing the impact of the biopsy, 
have been retrospective and were designed to explore post cancer 
treatment voice outcomes, with the potential for possible impact from 
the biopsy procedure only discussed as a post hoc, secondary measure. 
In addition, no study has compared voice function at the specific time-
points of pre and post biopsy. 
However despite these limitations, authors argue that the greater 
the excisional tumour/tissue removal the greater the grade of dysphonia 
[17-19]. Others propose that the process of stripping of the vocal cords 
versus a simple biopsy procedure may result in greater deviant voice 
characteristics [12,18]. In contrast, some authors suggest no difference 
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in long term post treatment voice outcomes for patients who had 
undergone stripping versus a simple biopsy procedure [11,13]. Finally, 
several studies now suggest that the excisional biopsy should be the 
procedure of preference given its dual diagnostic and therapeutic 
purpose [14,16,17] and the potential to preserve vocal fold function 
[14].
Currently there is an absence of any direct evidence that has 
examined the impact of the biopsy procedure on voice outcomes. If, 
indeed, a certain type or specific biopsy process was a potential factor 
in contributing to eventual post treatment voice outcomes, such 
information would be beneficial for improving biopsy technique for 
best clinical practice. Given this, and the paucity of systematic, well-
designed studies, this is an area in need of further research. This pilot 
study aims to prospectively investigate the biopsy procedure and its 
impact, if any, on voice outcomes for a cohort of early glottic cancer 
patients (Tis-T2).
Method
Ethical considerations
This study is part of a larger clinical research trial at Sahlgrenska 
University Hospital, Gothenburg, Sweden, exploring voice outcomes 
following non-surgical laryngeal cancer management. Ethics have been 
approved by the Regional Research Ethics Committee, University of 
Gothenburg, Sweden and conducted in accordance with the Declaration 
of Helsinki. All participants have given their informed consent.
Study population
Patients diagnosed with laryngeal cancer in the Västra Götaland 
Region were referred to a weekly tumour conference at the 
Otorhinolaryngology Department, Sahlgrenska University Hospital. 
From here they were recruited into the larger trial. As part of that 
protocol, all consenting patients underwent voice assessments at 
multiple time points relative to treatment, including pre and post 
biopsy. For inclusion in the current investigation, only those patients 
who had; (1) been diagnosed with early (Tis-T2) glottic cancer; (2) 
completed pre-biopsy voice recordings within one week of the biopsy 
procedure, and; (3) completed voice recordings post-biopsy between 
the second and sixth week post biopsy, were included in this pilot study. 
Of the 32 patients with pre post biopsy data, 17 did not meet 
inclusion criteria, secondary to; (1) one or several biopsies occurring 
before the first voice recording, n=6, and (2) patient voice recordings 
outside of above inclusion time-frames, n=11. The final cohort within 
this pilot study consisted of 15 patients (13 male, two female, 53% 
smoking, mean age 59 years, SD 11.44, range 47-79) – see Table 1. 
Participants had received a range of biopsy procedures (Table 1), 
reflective of the current clinical practice. For two participants, the nature 
of the biopsy operation was unavailable. All presented perceptually as 
having some degree of dysphonia pre biopsy. One third of the group 
presented with a severe grade of dysphonia, one third presented with 
moderate dysphonia and one third, a degree of mild dysphonia pre 
biopsy. A healthy control group (n=15) was recruited for comparison 
which was matched for gender, comparable for age (61 years, SD 8.29, 
range 47-79) and proportion of smokers (47%). Statistical comparisons 
confirmed age (t= 0.59) and proportion smoking status (χ2= 0.13, P= 
0.72) were not significantly different between the cohorts. The absence 
of laryngeal pathology within the control group was confirmed by an 
Otolaryngologist via nasolaryngoscopy.
Voice recordings
Voice recordings, for both the participant and control group, 
consisted of the reading of a standard passage and the maximum 
sustained vowel /a/, repeated three times. A headset microphone 
(Sennheiser MKE 2-p) was set at a distance of 12 cm from the corner of 
the mouth. Recordings were made at a sampling frequency of 44.1 kHz 
with a Panasonic Professional Digital Audio Tape (DAT) Recorder SV-
3800. Prior to analysis, all recordings were transferred from a DAT to 
a computer hard drive as an audio file (.wav) using the program Swell 
Soundfile Editor, version 4.5 (Saven Hightech). 
Perceptual analyses
Perceptual ratings were conducted by two speech-language 
pathologists (SLP), and a third for consensus rating. Raters attended 
a half-day’s consensus training based on Iwarsson and Petersen 
(2012) [20] and anchor samples were produced and incorporated 
into the final rating file. The final rating file was compiled using an 
excerpt from each control person’s voice recording and each patient’s 
pre- and post-biopsy voice recording. This excerpt (.wav audio file) 
n=15 Gender
M= Male
F= female
Age at 
biopsy
Biopsy location and type Tumour size and description Dysphonia severity 
pre biopsy
Dysphonia severity 
post biopsy
1 M 60 Bilateral punch biopsies# Tis 1 2*
2 M 56 Left punch biopsy T1a invasive tumour 3 3
3 M 79 Right punch biopsy T1a verrucous tumour 3 2*
4 F 51 Right punch biopsy T1a tumour encasing entire right VF 3 3
5 M 56 Bilateral punch biopsies# T1b, left VF polyp-like lesion, right 
leukoplasia
1 3*
6 M 64 Left excisional biopsy T1a tumour growth along half of left VF. 2 1*
7 M 71 Left excisional T1a tumour growth superior anterior 1/3 VF 1 1
8 M 50  Right excisional T1a 1 1
9 M 71 Left excisional T1a 2 2
10 M 46 Left VF biopsy, not described T1a tumour 1 1
11 M 41 Left punch T2 tumour encasing left VF 3 3
12 M 63 Right punch biopsies# T2 tumour encasing right VF 2 3*
13 M 76 Left excisional T2 large exophytic tumour 2 1*
14 F 48 Left excisional T2 tumour tissue encasing entire VF 2 2
15 M 53  Stripping of right VF T2 right tumour encasing anterior 2/3 VF 3 2*
Note: VF = vocal fold, * indicates perceived change in voice quality pre post biopsy, # denotes several biopsy samples taken.
Table 1. Patient demographics.
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included the first two sentences of the standard passage and the second 
recorded prolonged vowel /a/. Fifteen percent (7/45) of these samples 
were randomly chosen to be reduplicated for intra-rater reliability 
calculations. All samples (n=52) were then randomly compiled with 
the anchor samples interspersed, at every 20 voice samples, into the 
final rating file on a USB. The raters were blinded to participant/
patient status and voice sample information. The rating protocol used 
the GRBAS scale [21], which consists of 5 voice qualities: Grade (G), 
Roughness (R), Breathiness (B), Asthenia (A), and Strain (S). Each 
voice quality is rated on a 4-point scale, where 0 = normal, 1 = mildly 
impaired, 2 = moderately impaired and 3 = severely impaired. Inter and 
intra-rater reliability were calculated for the two raters using percent 
exact agreement (PEA), percent close agreement (PCA: one-point 
difference) and Weighted Kappa, interpreted using Landis and Koch 
guidelines [22]. Inter-rater reliability revealed a PEA of 53%, and PCA 
of 93%. Weighted Kappa was calculated at 0.66, indicating a substantial 
agreement. Intra-rater reliability revealed PEA 72%, and PCA 98% 
and a Weighted Kappa of 0.87, indicating an almost perfect intra-rater 
agreement. Where ratings differed between the two clinicians, a third 
clinician rated the parameter and consensus rating (two of three) was 
used in the analysis. 
Acoustic analyses
Voices were analysed using Voxalys 1.3 (Voxalys AB), a plugin 
programme to Praat [23]. Jitter, shimmer (perturbation measures 
which refer to the acoustic signal’s cycle-to-cycle variation in the 
fundamental frequency and amplitude, respectively) and Harmonics 
to Noise Ratio (HNR) values were analysed from two seconds of the 
middle of the second sustained vowel /a/. Mean speaking fundamental 
frequency (MSFF) was measured from reading of the standard passage. 
Aerodynamic analysis consisted of the Maximum Phonation Time 
(MPT) which is the longest recorded time (in seconds) for the sustained 
vowel /a/.
Statistics
Descriptive statistics using mean and standard deviation were 
calculated for perceptual, acoustic and aerodynamic voice measures. 
Statistical analyses were conducted using SPSS statistics software, 
version 21, except for the Weighted Kappa which was conducted using 
STATA 13. Significance was set at P<0.05. Due to small sample sizes 
and non-normal data distributions within the cohorts, non-parametric 
statistics were used for group comparisons. Differences pre to post 
biopsy in the patient cohort were analysed using the Wilcoxon Signed 
Rank Test. Comparisons between the patient and healthy control 
cohorts were analysed using Mann-Whitney U. In addition to group 
analysis, individual patterns were examined. The proportion and 
characteristics of individuals who demonstrated change in overall 
severity of dysphonia of one or more grade point on the GRBAS were 
noted. 
Results
Perceptual voice outcomes 
Table 2 reports the perceptual voice outcomes for the healthy control 
group, and the patient cohort at both pre and post biopsy. Relative to 
the control group, the patient group presented with significantly higher 
overall Grade of dysphonia, Roughness, Breathiness and Strain prior 
to biopsy. Post biopsy, the patient cohort remained significantly more 
impaired than controls for Grade, Breathiness and Strain. Roughness 
was no longer significantly different to the controls post biopsy. Visual 
examination of the pre-post biopsy patient group means, revealed 
Roughness to be the only parameter to show some degree of overall 
improvement pre to post biopsy, however the within-group analysis 
failed to support a significant change in GRBAS parameters post biopsy 
(Table 2).
Acoustic and aerodynamic analyses 
Pre biopsy, statistically significant differences were observed 
between the larynx cancer patients and controls on HNR, jitter, 
shimmer and male MSFF (Table 3). Post biopsy, only shimmer and 
male MSFF continued to show a significant difference to the control 
group. Visual inspection of pre-post biopsy means suggest a pattern 
of slight improvement of HNR and slight decline in jitter post biopsy, 
however no acoustic parameter was found to be statistically different 
pre to post biopsy (Table 3). The aerodynamic measure of MPT did not 
differ significantly pre to post biopsy or when compared to controls.
Exploratory analyses 
Although no significant pre-post biopsy changes were demonstrated 
at a cohort level, individually, seven patients (Table 1) showed a 
perceived change in voice quality pre-post biopsy. Of these seven, four 
individuals (patients 3, 6, 13 and 15) showed an improvement in their 
level of dysphonia. Examination of patient characteristics, revealed no 
dominant patterns regarding size of tumor nor type of biopsy procedure 
for these four relative to the rest of the group. The remaining three 
individuals (patients 1, 5 and 12) demonstrated deterioration in vocal 
function post biopsy. All three underwent multiple biopsies, all punch, 
with two of the three perceived to deteriorate to severe dysphonia post 
multiple biopsies. 
Discussion
This is the first study to prospectively investigate the biopsy 
procedure and its direct impact on voice function for patients with 
early glottic cancer (Tis-T2). By comparing the patient data to a control 
cohort, the current study has confirmed that patients with Tis - T2 size 
tumors have significant perceptual and acoustic voice impairments pre 
biopsy and continue to remain with a pathological voice post biopsy. 
The primary reason for this dysphonia would likely be the negative 
impact of the tumor growth on normal vocal fold function. Post 
Parameter Healthy Controls
mean (SD)
Patient pre-biopsy
mean (SD)
Patient post-biopsy
mean (SD)
Comparisons
Pre-post biopsy
P-value
Control vs Patient 
pre-biopsy P-value
Control vs Patient 
post-biopsy P-value
Grade 0.53 (0.52) 2.00 (0.85) 2.00 (0.85) 1.000 0.000  0.000
Roughness 0.33 (0.49) 1.27 (0.88) 0.93 (1.10) 0.212 0.003  0.130
Breathiness 0.20 (0.41) 1.27 (1.03) 1.47 (0.99) 0.317  0.001  0.000
Asthenia 0.00 (0.00) 0.00 (0.00) 0.07 (0.26) 0.317  1.000  0.317
Strain 0.20 (0.41) 1.53 (0.99) 1.53 (0.74) 0.957  0.000  0.000
Note: Significance = P<0.05, indicated by bolded font. SD = standard deviation.
Table 2. Perceptual data for patient (n=15) and control (n=15) groups.
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biopsy, however, comparison of the patient data to the control group, 
revealed that some perceptual and acoustic changes had occurred, with 
some parameters no longer significantly different to the control group 
performance. As such, it may be suggested that these small shifts in 
function may be due to the removal of tumour tissue as supported by 
some authors [14-16]. 
Examination of vocal change pre and post biopsy, however, revealed 
no statistically significant difference on the perceptual, acoustic or 
MPT parameters. On the basis of this finding, it would appear that the 
biopsy process has minimal or no impact on functional outcomes for 
early glottic cancer. Although the nature of the biopsy is to remove 
tissue which could then potentially damage the vocal folds, it is possible 
in some cases, such as with exophytic tumours, to phonosurgically 
remove suspect tissue yet preserve the underlying vocal folds as 
suggested by Melchiors and colleagues [14]. This pilot study, however, 
did not consistently collect tumour information (exophytic vs. 
invasive), involvement of the anterior commissure, nor exact volume 
or type of tissue removed (cancerous versus mucosal, ligamental or 
muscular tissue), therefore such potential voice impacting factors 
currently cannot be confirmed. In fact, the results of this study are 
more congruent with those studies which suggest that type of biopsy 
do not impact voice outcomes [11,13]. 
Another possible reason for no significant mean change at a group 
level may be due to the pilot study’s small sample size and the individual 
variability within our sample. As revealed by our case by case analysis, 
half of the group remained unchanged post biopsy on perceptual 
assessment. However, within the other half, four showed improvements 
and three showed voice deterioration. Exploration of the patient 
characteristics for those with improved vocal function, failed to reveal 
any clear pattern in relation to nature of tumour or biopsy procedure. 
However, in contrast, the three voice deterioration cases were all punch 
and biopsied multiple times. This outcome is congruent with authors 
who have suggested that the punch biopsy may be detrimental to the 
voice [14] and, furthermore, is an inferior procedure since a single 
biopsy sample may not be representative, histologically, of the entire 
pathological tissue [17,24]. In this study, where patients underwent 
several punch samples and multiple biopsy procedures, a deterioration 
to moderate-severe dysphonia was consistently demonstrated. These 
aforementioned authors and others go on to suggest that the excisional 
biopsy is the procedure of preference since the punch biopsy may be 
likely to harm the vocal cords and the excisional biopsy has the dual 
purpose of being both diagnostic and therapeutic in a single procedure 
[14,16,17,24]. Claims made by these studies, however, need to be 
interpreted with caution since specific voice and functional outcomes 
were not recorded nor rigorously investigated in their study designs. 
Strengths and limitations
Although this is the first prospective study, to date, investigating 
voice outcomes pre and post biopsy, several limitations in this pilot 
study have been identified. This study did not control for types of 
tumours, and biopsy procedures were not standardized but dependent 
on surgeon preference, as is reflective of clinical practice. Multiple surgeons 
across several sites were involved and the operation report (biopsy 
procedure description) was not always detailed. The small sample size is 
also a limitation since biopsy technique, tumour size and tumour type as 
possible factors influencing the post biopsy voice cannot be conclusively 
suggested with this small sample size. Power calculations (G*Power 3.1.9.2 
software [25]), using a priori, 2-tailed, Laplace distribution with a power 
of 80%, 5% level of significance and effect size of 0.3) suggest that a n=60 
would be required in future studies. 
However, despite the lack of pre post biopsy group mean statistical 
difference, the fact that half of the patients showed voice changes 
post biopsy procedure, suggests that this is an area in need of further 
research. Future studies should control for types of tumours and biopsy 
procedures, as far as clinically possible, with a recommended sample 
size of 60 for adequate power (80%). Pre-post biopsy voice outcomes 
should be routinely collected in clinical practice.
Conclusion
Although it is well established that the biopsy is a necessary first 
step in laryngeal cancer management, there is emerging discussion and 
debate surrounding suggested optimal biopsy technique in terms of 
functional sequelae. In this small cohort, a positive or negative biopsy-
voice impact was not confirmed; although individual analyses supported 
the notion of a negative voice change in those who underwent multiple, 
punch biopsies. Consequently, this study indicates that type of biopsy, 
nature and extent of tumour/tissue removal on functional outcomes is 
an area of further research. 
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Parameter Controls 
mean (SD)
Patient 
pre biopsy
mean (SD)
Patient 
post biopsy
mean (SD)
Comparisons
Patient 
pre-post biopsy
P-value
Control vs. Patient 
pre biopsy
P-value
Control vs. Patient 
post biopsy
P-value
HNR 19.38 (5.17) 13.10 (6.80) 14.78 (7.16) 0.125  0.026  0.059
Jitter 0.76  (0.96) 1.13  (0.84) 1.22 (1.04) 0.394  0.021  0.071
Shimmer 0.35 (0.19) 0.79 (0.59) 0.64 (0.38) 0.140  0.04  0.040
MSFF (males) (n=13) 113.19 (16.49) 131.52 (22.54) 128.26 (16.97) 0.158  0.013  0.026
MSFF (females) (n=2) 178.45 (6.43) 170.70 (7.35) 159.95 (10.96) 0.655  0.439  0.121
MPT 15.53 (5.4) 13.75 (9.39) 11.90 (6.80) 0.334  0.206  0.110
Note: HNR = harmonics to noise ratio, MSFF = mean spoken fundamental frequency, MPT = maximum phonation time. Statistical significance at P<0.05, indicated by bolded font. SD = 
standard deviation.
Table 3. Acoustic and aerodynamic results for patient (n=15) and control (n=15) groups.
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